Daiwa Capital Markets America’s Dr. Reddy's Laboratories RDY Stock Holding History

Daiwa Capital Markets America’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	$86K	Buy	+10,500	New	+$83.1K	﹤0.01%	778

Other funds holding RDY

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

BlackRock Group London, United Kingdom $210B AUM 15.76% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Daiwa Capital Markets America's RDY Position: Q4 2013 in Review

Daiwa Capital Markets America opened a new position in Dr. Reddy's Laboratories (RDY) in Q4 2013: 10,500 shares worth $86K. The stake represents ﹤0.01% of the portfolio and ranks #778 among its holdings.

149 funds tracked by Wall St. Rank hold RDY as of Q4 2013.

Daiwa Capital Markets America held 10,500 shares of Dr. Reddy's Laboratories worth $86K as of Q4 2013.
Dr. Reddy's Laboratories was a new Daiwa Capital Markets America position in Q4 2013.
Dr. Reddy's Laboratories made up ﹤0.01% of Daiwa Capital Markets America's portfolio in Q4 2013, its #778 holding.
149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2013.

Based on Daiwa Capital Markets America's 13F filing for Q4 2013, filed 13 Feb 2014.